By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Novo Nordisk A/S 

Novo Allé

Bagsvaerd    2880  Denmark
Phone: 45-4444-8888 Fax: 45-4449-0555


Big Pharma


CelTor Biosystems, Inc.  Research collaboration

Aradigm Corporation  Commercial agreement to develop AERx technology for the delivery of insulin, insulin analogues and other glucose-lowering agents for diabetes management.


Maxygen, Inc. 

Intergen Company 

Company News
Novo Nordisk A/S (NVO) And NBA Legend Dominique Wilkins Launch My Diabetes Dream Team Sweepstakes 7/21/2015 1:25:41 PM
Novo Nordisk A/S (NVO) Receives FDA Approval For FlexPro PenMate For People With Growth Hormone-Related Disorders 7/16/2015 11:37:16 AM
Novo Nordisk A/S (NVO) Terminates GLP-1 Patch Deal with Zosano 7/6/2015 7:03:32 AM
Novo Nordisk A/S (NVO) Pulls Tresiba Off Shelves in Germany 7/2/2015 6:21:06 AM
New Novo Nordisk A/S (NVO) Data Demonstrate Caregiver Burden And Prevalence Of Pain In People Living With Hemophilia 6/24/2015 8:26:50 AM
Novo Nordisk A/S (NVO) Release: In A Phase 3 Trial, Novoeight(Antihemophilic Factor [Recombinant]) Provided Long-Term Efficacy And Safety In The Prophylaxis And Treatment Of Bleeds In People With Hemophilia A 6/24/2015 6:37:59 AM
Novo Nordisk A/S (NVO) Release: New IDegLira Phase 3b Study Showed Statistically Significant HbA1c Reduction, Body Weight Change, And Lower Rate Of Hypoglycaemia Versus Insulin Glargine 6/8/2015 6:11:12 AM
Novo Nordisk A/S (NVO)'s $225 Million Hemophilia Facility Will Create 100 New Jobs 5/4/2015 7:27:34 AM
Novo Nordisk A/S (NVO) CEO Candidate Abruptly Departs and Company Starts Hunt Afresh 4/30/2015 6:01:39 AM
Novo Nordisk A/S (NVO) Announces Saxenda (Liraglutide [Rdna Origin] Injection) Is Now Commercially Available In The United States 4/22/2015 11:29:43 AM